I'm hoping the last comment turns from Cap raise to "capital investor" but lets see. Its a toss up with what would be better for us in the short....or long term. IMO only is that there is enough shares on issue now without anymore more dilution for us so I'd like to see a big name pharma invest in our first drug for the market to take notice & to build confidence in PYC as a notable BIO to pave the way for the big $ kidney drug & others..........stepping stone.... IMO, this is when the market wakes up (based on what we have seen many times in the past with others) when a major pharma takes on the $ risk which generates a lower risk investment for others to jump in knowing that the data and chances then to success are backed & much better odds of success. The SP then runs very hard and stabilises with others knowing that there is much much higher chance of success when these big dogs invest their capital into a lengthy commercialisation journey before the stakes get too high for success for them to be any part of that journey...
GLTAH.
PYC Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)